Trial Profile
Phase II trial of EVT 101 in patients with neuropathic pain.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs EVT 101 (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Evotec SE
- 20 Nov 2007 New trial record.